42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      ROS Production and NF-κB Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          The Adenomatous Polyposis Coli ( APC) gene is mutated in the majority of colorectal cancers (CRCs). Loss of APC leads to constitutively active WNT signaling, hyperproliferation, and tumorigenesis. Identification of pathways that facilitate tumorigenesis after APC loss is important for therapeutic development. Here, we show that RAC1 is a critical mediator of tumorigenesis after APC loss. We find that RAC1 is required for expansion of the LGR5 intestinal stem cell (ISC) signature, progenitor hyperproliferation, and transformation. Mechanistically, RAC1-driven ROS and NF-κB signaling mediate these processes. Together, these data highlight that ROS production and NF-κB activation triggered by RAC1 are critical events in CRC initiation.

          Graphical Abstract

          Highlights

          • RAC1 is required for tumorigenesis after APC loss

          • LGR5 ISC transformation requires RAC1

          • RAC1-driven ROS production and NF-κB activation are required for CRC initiation

          Abstract

          This study demonstrates that RAC1-mediated ROS production and NF-KB activation is required for LGR5 stem cell expansion and colorectal cancer initiation after loss of the APC gene.

          Related collections

          Author and article information

          Contributors
          Journal
          Cell Stem Cell
          Cell Stem Cell
          Cell Stem Cell
          Cell Press
          1934-5909
          1875-9777
          06 June 2013
          06 June 2013
          : 12
          : 6
          : 761-773
          Affiliations
          [1 ]Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK
          [2 ]Institute of Molecular Immunology, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany
          [3 ]Department of Pathology, Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
          Author notes
          []Corresponding author o.sansom@ 123456beatson.gla.ac.uk
          Article
          STEM1329
          10.1016/j.stem.2013.04.006
          3690525
          23665120
          55eca0f3-9184-4f8c-89a3-eccba906ecef
          © 2013 ELL & Excerpta Medica.

          This document may be redistributed and reused, subject to certain conditions.

          History
          : 10 January 2012
          : 27 November 2012
          : 8 April 2013
          Categories
          Article

          Molecular medicine
          Molecular medicine

          Comments

          Comment on this article

          Related Documents Log